Product Details
Lamictal
Lamotrigine5 mg
Chewable Tablet
DIN/PIN/NPN
02240115
Manufacturer
GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
Formulary Listing Date
2023-04-28
Unit Price
0.2070
Amount MOH Pays
0.2070
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
N03AX09
Interchangeable Products
NOLU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Anticonvulsants | Lamotrigine (chewable)
For the adjunctive therapy for children over 2 years of age who are suffering from refractory seizures associated with Lennox-Gastaut syndrome, and who have previously tried other antiepileptic drugs. |